PTGX
Protagonist Therapeutics, Inc.NASDAQStock$98.73-2.48 (-2.45%)Mkt Cap 6.3BP/E —Div Yield —Beta 2.11Vol 174.1KAvg Vol 713.2K
52W$42.01
$105.98
ETFs That Hold PTGX (Protagonist Therapeutics, Inc.)
1M
-1.14%
3M
+23.83%
6M
+25.58%
YTD
+13.25%
1Y
+116.42%
3Y
+319.24%
5Y
+241.15%
ETFs That Hold PTGX
Protagonist Therapeutics, Inc. is held by 130 ETFs. The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
| ETF | Fund Name | Weight |
|---|---|---|
| FTXH | First Trust Nasdaq Pharmaceuticals ETF | 0.58% |
| TILT | FlexShares Morningstar U.S. Market Factor Tilt Index Fund | 0.01% |
| AFMC | First Trust Active Factor Mid Cap ETF | 0.11% |
| RFLR | Innovator U.S. Small Cap Managed Floor ETF | 0.20% |
| FSML | Franklin Small Cap Enhanced ETF | 0.10% |
| AOA | iShares Core 80/20 Aggressive Allocation ETF | 0.00% |
| AOR | iShares Core 60/40 Balanced Allocation ETF | 0.00% |
| SPGM | State Street SPDR Portfolio MSCI Global Stock Market ETF | 0.01% |
| ROSC | Hartford Multifactor Small Cap ETF | 0.17% |
| OASC | OneAscent Small Cap Core ETF | 0.30% |
| ACSG | American Century Small Cap Growth Insights ETF | 0.51% |
| LSLT | Pacer Salt Low truBeta US Market ETF | 0.00% |
| PWS | Pacer WealthShield ETF | 0.22% |
| SLT | Pacer Salt High truBeta US Market ETF | 0.00% |
| TRPL | Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF | 0.00% |
| VETS | Pacer Military Times Best Employers ETF | 0.00% |
| VIRS | Pacer BioThreat Strategy ETF | 0.00% |
| TNXT | T. Rowe Price Innovation Leaders ETF | 0.42% |
| RWJ | Invesco S&P SmallCap 600 Revenue ETF | 0.00% |
| CSA | VictoryShares US Small Cap Volatility Wtd ETF | 0.22% |
Excludes leveraged and inverse ETFs.
Frequently Asked Questions
How many ETFs hold PTGX?
Protagonist Therapeutics, Inc. (PTGX) is held by 130 ETFs (excluding leveraged and inverse funds). The largest position by market value is in IJR (iShares Core S&P Small-Cap ETF).
What is the largest ETF that holds PTGX?
By fund size, IJR (iShares Core S&P Small-Cap ETF) with $101.65B in AUM holds 0.36% of its portfolio in PTGX, representing $366.3M in market value.
What percentage of PBE is PTGX?
PTGX makes up 3.31% of PBE (Invesco Biotechnology & Genome ETF), making it one of the largest positions in that fund.
Is PTGX in the S&P 500?
PTGX is not currently a component of the S&P 500 index based on available ETF holdings data.
FREE DOWNLOAD
The Beginner's Guide to ETFs
20 pages. Zero fluff. Everything you need to start investing in ETFs.
No spam. Unsubscribe anytime.